FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

782980002: Emapalumab (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3757043015 Emapalumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3757044014 Emapalumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Emapalumab This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Interferon gamma inhibitor true Inferred relationship Some
Emapalumab Is a Monoclonal antibody true Inferred relationship Some
Emapalumab Is a Interferon gamma inhibitor true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing emapalumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Emapalumab Inferred relationship Some 1
Emapalumab only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Emapalumab Inferred relationship Some 1
Product containing emapalumab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Emapalumab Inferred relationship Some 1
Emapalumab only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Emapalumab Inferred relationship Some 1

This concept is not in any reference sets

Back to Start